Penzberg, Germany

Vincent Larraillet

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2022.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vincent Larraillet: Innovator in Antibody Analysis

Introduction

Vincent Larraillet is a notable inventor based in Penzberg, Germany. He has made significant contributions to the field of antibody analysis, particularly through his innovative patent. His work focuses on improving the understanding and detection of multispecific antibodies.

Latest Patents

Vincent Larraillet holds a patent titled "Method for detecting multispecific antibody light chain mispairing." This patent describes the use of a limited digestion with a proteolytic enzyme of a multispecific antibody for the analysis of the multispecific antibody's light chain pairing. This innovative method enhances the accuracy of antibody analysis, which is crucial for various applications in biotechnology and medicine. He has 1 patent to his name.

Career Highlights

Throughout his career, Vincent has worked with prominent companies in the pharmaceutical industry. He has been associated with Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG, where he contributed to various research and development projects. His expertise in antibody technology has been instrumental in advancing the field.

Collaborations

Vincent has collaborated with several professionals in his field, including Michael Molhoj and Maximiliane Koenig. These collaborations have allowed him to expand his research and contribute to innovative solutions in antibody analysis.

Conclusion

Vincent Larraillet is a distinguished inventor whose work in antibody analysis has made a significant impact in the field. His innovative methods and collaborations continue to influence advancements in biotechnology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…